OCT angiography interview with Dr. Kester Nahen
Dr. Kester Nahen, Managing Director of Heidelberg Engineering, explains in this interview the diagnostic potential and limitations of OCT angiography*.
This novel technology makes it possible to visualize distinct vascular networks at different depths in the retina and does not require a contrast agent, so the associated risks of dye injection are eliminated. Compared with traditional fluorescence angiography (i.e. fluorescein and indocyanine green angiography), this new method offers thus both clinical and practical advantages, although it does come with its physical limitations.
This interview was originally published in German by the trade journal CONCEPT Ophthalmologie and has now been translated into English.
*The SPECTRALIS OCT Angiography Module is under development and not for sale yet.